Literature DB >> 10611490

Binding of IL-4 to the IL-13Ralpha(1)/IL-4Ralpha receptor complex leads to STAT3 phosphorylation but not to its nuclear translocation.

S Wery-Zennaro1, M Letourneur, M David, J Bertoglio, J Pierre.   

Abstract

Interleukin-4 (IL-4) is a pleiotropic cytokine, which acts on both hematopoietic and non-hematopoietic cells, through different types of receptor complexes. In this study, we report that in human B cells, IL-4 caused rapid phosphorylation of Janus kinase (JAK) 1 and JAK3 tyrosine kinases. In keratinocytes, the hematopoietic-specific receptor common gamma(c) chain is not expressed and the IL-13 receptor alpha(1) (IL-13Ralpha(1)) participates in IL-4 signal transduction. In keratinocytes, IL-4 induced JAK1 and JAK2 phosphorylation but, unlike in immune cells, IL-4 did not involve JAK3 activation for its signaling. In both cell types, IL-4 induced phosphorylation and DNA binding activation of the signal transducer and activator of transcription (STAT) 6 protein. Furthermore, IL-4 stimulation of keratinocytes also induced tyrosine phosphorylation of STAT3 which was found to bind to the phosphorylated IL-13Ralpha(1). STAT3 however did not significantly translocate to the nucleus, nor did it bind with high affinity to target DNA sequences.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10611490     DOI: 10.1016/s0014-5793(99)01680-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  IL-27 and type 2 immunity in asthmatic patients: association with severity, CXCL9, and signal transducer and activator of transcription signaling.

Authors:  Min Xie; Anthony T Mustovich; Yi Jiang; John B Trudeau; Anuradha Ray; Prabir Ray; Haizhen Hu; Fernando Holguin; Bruce Freeman; Sally E Wenzel
Journal:  J Allergy Clin Immunol       Date:  2014-10-11       Impact factor: 10.793

2.  IL-17A enhances IL-13 activity by enhancing IL-13-induced signal transducer and activator of transcription 6 activation.

Authors:  Sara L Hall; Theresa Baker; Stephane Lajoie; Phoebe K Richgels; Yanfen Yang; Jaclyn W McAlees; Adelaide van Lier; Marsha Wills-Karp; Umasundari Sivaprasad; Thomas H Acciani; Timothy D LeCras; Jocelyn Biagini Myers; Melinda Butsch Kovacic; Ian P Lewkowich
Journal:  J Allergy Clin Immunol       Date:  2016-06-11       Impact factor: 10.793

3.  In vitro assessment of IL-4- or IL-13-mediated changes in the structural components of keratinocytes in mice and humans.

Authors:  Miyuki Omori-Miyake; Masakatsu Yamashita; Yuichiro Tsunemi; Makoto Kawashima; Junji Yagi
Journal:  J Invest Dermatol       Date:  2013-11-26       Impact factor: 8.551

Review 4.  IL-13 receptor isoforms: breaking through the complexity.

Authors:  Yasuhiro Tabata; Gurjit K Khurana Hershey
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

Review 5.  Anti-Inflammatory Targets for the Treatment of Reperfusion Injury in Stroke.

Authors:  Atsushi Mizuma; Midori A Yenari
Journal:  Front Neurol       Date:  2017-09-07       Impact factor: 4.003

6.  JAK3 as an Emerging Target for Topical Treatment of Inflammatory Skin Diseases.

Authors:  Ana Karina Alves de Medeiros; Reinhart Speeckaert; Eline Desmet; Mireille Van Gele; Sofie De Schepper; Jo Lambert
Journal:  PLoS One       Date:  2016-10-06       Impact factor: 3.240

7.  Detection of a functional hybrid receptor gammac/GM-CSFRbeta in human hematopoietic CD34+ cells.

Authors:  J Giron-Michel; M Fogli; A Gaggero; S Ferrini; A Caignard; D Brouty-Boye; S Baouz; M-C Le Bousse-Kerdiles; B Peault; M van Dijk; S Bulfone-Paus; D Durali; S Chouaib; B Azzarone
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

8.  Distinct signal transduction processes by IL-4 and IL-13 and influences from the Q551R variant of the human IL-4 receptor alpha chain.

Authors:  Susanne Kruse; Sandra Braun; Klaus A Deichmann
Journal:  Respir Res       Date:  2002-08-14

Review 9.  The involvement of the JAK-STAT signaling pathway in chronic inflammatory skin disease atopic dermatitis.

Authors:  Lei Bao; Huayi Zhang; Lawrence S Chan
Journal:  JAKSTAT       Date:  2013-08-15

10.  Tocilizumab inhibits neuronal cell apoptosis and activates STAT3 in cerebral infarction rat model.

Authors:  Shaojun Wang; Jun Zhou; Weijie Kang; Zhaoni Dong; Hezuo Wang
Journal:  Bosn J Basic Med Sci       Date:  2016-01-15       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.